bioAffinity Technologies (BIAFW) Interest & Investment Income (2021 - 2026)
bioAffinity Technologies (BIAFW) posted quarterly Interest & Investment Income of $10026.0 for Q1 2026, up 1749.82% YoY from $542.0 in Q1 2025, and down 49.18% sequentially from $19730.0 in Q4 2025.
bioAffinity Technologies (BIAFW) Interest & Investment Income (2021 - 2026) Analysis & Trends
bioAffinity Technologies has disclosed Interest & Investment Income across 6 years of filings, most recently posting $10026.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 1749.82% year-over-year to $10026.0; the TTM figure through Mar 2026 stood at $32869.0 (up 173.34% YoY), while the FY2025 annual figure was $23385.0, up 32.79% from the prior year.
- Interest & Investment Income eased to $10026.0 in Q1 2026, from $19730.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for BIAFW reached as high as $44124.0 in Q2 2023 and fell as low as $276.0 in Q2 2022.
- The 5-year median for Interest & Investment Income is $6770.5 (2022), against an average of $13705.6.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 38921.05% — and 2024, when it plunged 91.81%.
- A 5-year view of Interest & Investment Income shows it stood at $38447.0 in 2022, then plunged by 68.37% to $12160.0 in 2023, then sank by 66.54% to $4069.0 in 2024, then soared by 384.89% to $19730.0 in 2025, then tumbled by 49.18% to $10026.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $10026.0, $19730.0, and $1088.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 6.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 233.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 27.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 597,000.00 |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 13.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 10.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 11.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | bioAffinity Technologies | - | - | - | 10,026.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,026.00 |
| Dec 31, 2025 | 19,730.00 |
| Sep 30, 2025 | 1,088.00 |
| Jun 30, 2025 | 2,025.00 |
| Mar 31, 2025 | 542.00 |
| Dec 31, 2024 | 4,069.00 |
| Sep 30, 2024 | 2,228.00 |
| Jun 30, 2024 | 5,186.00 |
| Mar 31, 2024 | 6,127.00 |
| Dec 31, 2023 | 12,160.00 |
| Sep 30, 2023 | 27,193.00 |
| Jun 30, 2023 | 44,124.00 |
| Mar 31, 2023 | 38,654.00 |
| Dec 31, 2022 | 38,447.00 |
| Sep 30, 2022 | 7,414.00 |
| Jun 30, 2022 | 276.00 |
| Dec 31, 2021 | 400.00 |
| Sep 30, 2021 | 19.00 |